SpeeDx has announced signing new partners Al Zahrawi Medical Supplies LLC for distribution of ResistancePlus®&n...
A research team led by Dr Ben Goudey at IBM Research – Australia is using machine learning (ML) to ident...
Atos, a global leader in digital transformation, has signed an AUD124 million (approx. EUR78.2 ...
Medicines Australia recently recognised the extraordinary talent in the Australian Pharmaceutical sector workforce at th...
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing n...
The Australian Government is investing more than $200 million to list four new breakthrough cancer treatments on the Pha...
RespireRx Pharmaceuticals Inc., a leader in the research and development of cannabinoids for the treatment of sleep-rela...
Australia based diagnostic company, Minomic International Ltd has announced that the company has executed an agreement w...
Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Ar...
Mayne Pharma Group Limited has announced the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United ...
Cartherics and panCELLa have announced their collaboration to research, develop and commercialize products for the treat...
SpeeDx Pty. Ltd. has announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration ...
Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue,...
The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...
Strides Pharma Science Limited (Strides) has announced that its step-down subsidiary Strides Pharma Global Pte, Limited,...
The iQ Group Global, a consortium of life science and financial services companies which span the biopharma value chain ...
Australia-based Mayne Pharma is pleased to announce the launch of TOLSURA (SUBA®-itraconazole) 65mg capsule in the U...
UK patients with N. gonorrhoeae (GC) now have the option of receiving the cheap and easily-administered o...
